In lung, liver and breast cancer cells (MCF7; luminal A and CREB3L1-deficient), lanatoside C was shown to selectively kill cancer cells by arresting the cells in G2 and M phase, likely through effects on the JAK/STAT and PTEN/p53 signaling pathways28. The gene discussed is PTEN; the disease is breast carcinoma.